Virtual Visits Market - Global Outlook and Forecast 2022-2027

Virtual Visits Market - Global Outlook and Forecast 2022-2027

The global virtual visits market is expected to grow at a CAGR of 27.15% during 2022-2027.

In the virtual visit, a patient or medical professional uses a computer, smartphone, or tablet to obtain a diagnosis and send a prescription to their pharmacy. The visit is completed without leaving home or the workplace and amounts to far less than the cost of an emergency room or primary care office visit. Virtual visits are available to Health Action Council members and their employees from various vendors and providers. With the increasing telehealth utilization, there is also an increase in the adoption of virtual visit platforms. From 2017 to 2019, the virtual visit doubled for Health Action Council members.

Virtual care offers an easier, faster way to find and see a provider. Less than 2% of outpatient behavioral health and medical claims have been for virtual visits. According to CDC reports, virtual care has seen a 50% increase in March 2020 and continued to increase as lockdowns continued worldwide. According to studies, about 54% of respondents prefer to use virtual health as an option for consultation or diagnosis.

Throughout the COVID-19 pandemic, people have shifted to virtual care for medical and behavioral care because of convenience, ease of schedule, and have been found safe to avoid crowded waiting rooms. A recent report shows that about 76% of people are interested in using telehealth. Even after the pandemic ends, it is expected that about 83% of patients will use virtual care.

The following factors are likely to contribute to the virtual care market growth during the forecast period:

  • Rising reimbursements by insurers and the government during the COVID-19 pandemic
  • Rising adoption of patient care technology and growing digitalization
  • Increasing demand for personalized care in remote areas
  • Increasing Prevalence of chronic diseases and aging population
Advantages of Virtual Visits
  • Reduced waiting time
  • It saves the traveling time
  • Easy access to expertise and specialty physicians
  • Reduces overall cost of healthcare and treatment
  • Better disease management
The development of the telecommunication system has increased the scope of virtual care services immensely. With the introduction of virtual visit services, the growth of traditional medical diagnosis is growing at a moderate pace, especially in high-income countries where virtual visit has become a widespread practice for a consultation. The introduction of virtual visits has led to cost-effective treatment, adoption of home healthcare services, and low expenditure on infrastructure development. The virtual visit has revolutionized the healthcare industry as it reduces hospital visits, reduces patient wait time, and decreases the physical discomfort caused to patients. Further, globally, higher expenditure on healthcare IT by the major stakeholders in the healthcare industry is contributing to the global virtual visits market growth.

The rising incidences of chronic medical conditions such as diabetes and hypertension influence market growth. Virtual care is a valuable tool for continuous monitoring of chronic diseases and treatment. The adoption of virtual visit services is expected to rise with advancements in technology and high penetration of internet connectivity with more incredible speed & smart gadgets. Communication technologies (ICTs) and Modern information, such as computers, laptops, the Internet, and smartphones, are revolutionizing the communication among people that seek and exchange information and enriching their lives.

Artificial intelligence (AI) will add value and promote the virtual visit market growth. Artificial Intelligence paired with telehealth had been on the rise before the COVID-19, which created increased virtual visits capacity.

VENDORS' ACTIVITIES IN THE MARKET

The global virtual care market is highly dynamic and fragmented, with the presence of several international, regional, and local players. The key players in the market are AMD Global Telemedicine, American Well, Koninklijke Philips, and Teladoc Health.
  • Expansion activities (facility expansions and regional business) are helping players strengthen their market share and global distribution networks, thus allowing them to explore untapped opportunities.
  • Large-scale investments in the single-use bioprocessing probes and sensors market through varied conglomerates and investments firms
  • Forging partnerships and collaborations with well-established manufacturers cementing the footprints of the players
  • Active mergers and acquisitions play a vital role in the smooth functioning of the growth cycle.
  • The market is experiencing a surge in technological advancements in virtual care and the launch of new software and integrated hardware or devices or connected healthcare devices.
  • Vendors invest highly in integrating hardware or connected devices, software, and applications.
  • Key vendors operating in the market have demonstrated that they can provide reliable healthcare platforms to a large pool of patients at low cost or even zero cost per visit with the qualifying insurance plan in the US, depending on the type of visit.
  • Some key vendors offer services 24/7 in urgent care and provide on-demand video visits.
  • Many start-up companies are entering the market with the increased funding being received by the government and the private entities with innovative virtual visits platforms and solutions to gain traction among end-users
  • The key players make substantial R&D investments and develop innovative and technologically advanced products, thereby restricting small and medium-sized vendors from capturing higher market shares.
Major Vendors
  • AMD Global Telemedicine
  • American Well
  • Koninklijke Philips
  • Teladoc Health
Other Prominent Vendors
  • Banner Health
  • Beato
  • Blue Sky MD
  • Careclix
  • Cerner
  • CHI Health
  • Chiron Health
  • CVS Health
  • Dialogue
  • Doctor On Demand
  • Doxy(.) ME
  • Eagle Telemedicine
  • Edgemed Healthcare
  • eVisit
  • HealthTap
  • Health at Hand
  • HealthHero
  • Instapract
  • MDLive
  • MediBuddy
  • MFine
  • NeuroSynaptic Communications
  • Nextcare
  • Optum
  • Plushcare
  • Piedmont Healthcare
  • Practo
  • RO
  • Reecuro Health
  • SteadyMD
  • SOC Telemed
  • TRUDOC Healthcare
  • Vidyo
  • VSee
  • Walmart Health Virtual Care
  • Zipnosis
MARKET GROWTH ENABLERS
  • Rising reimbursements by insurers and the government during the COVID-19 pandemic
  • Rising adoption of patient care technology and growing digitalization
  • Increasing demand for personalized care in remote areas
  • Increasing Prevalence of chronic diseases and aging population
IMPACT OF COVID-19 PANDEMIC

Before the COVID-19 pandemic, the adoption of virtual visits remained low due to a lack of reimbursement, awareness, and internet connectivity. Also, there was a limited number of healthcare providers offering virtual visit services to medical professionals and patients. Telehealth had been around for years before the COVID-19 crisis; there are many regulatory bodies and state parity laws that limited reimbursement by Medicare, Medicaid, and private insurers, curbed allowable sites of care, and placed licensure restrictions on who can provide telehealth services.

Virtual visit services have increased during the COVID-19 pandemic worldwide; the government is permitted to make consultations via virtual visit platforms by relaxing the regulations and increasing reimbursements.

With the surge in COVID-19 cases, the virtual care market jumped from 30% in 2020 to 33% in 2021, while satisfaction with asynchronous telehealth services leveraging pictures and videos grew from 41% to 54% in the same period. In 2020, 53% of US patients said they were more satisfied with live video than with previous in-person interactions.

MARKET SEGMENT ANALYSIS

The service segment is the fastest-growing segment by component, with the highest revenue of USD 10.35 billion in 2021, whereas hardware and software generated $2.91 billion. Several vendors offer a wide range of services in various specialties. The healthcare providers provide services giving both the options of a scheduled or on-demand visit. The services have widely been adopted in high-income countries and are also expected to gain momentum in low-and-middle-income countries. The hardware and software segment is expected to grow at an excellent pace in the forecast period, with a CAGR of 26.20%.

General consultation is the fastest-growing segment, with a CAGR of 25.90%. There were full restrictions worldwide to go outside, and fear of getting COVID-19 infection within hospitals led to increased virtual visits worldwide. The chronic care management market is expected to grow due to the increasing prevalence of chronic diseases and the increasing elderly population. Chronic care management services also give cost-benefit as most of the service fee is cut to as low as $0, depending on the patient's insurance plan, thus saving the overall visit cost. Also, initiatives are increasing support for chronic care management virtual visit services.

Adults are the fastest-growing patient group because of their increasing use of virtual visits. The high population and increasing chronic diseases among adults, especially in the geriatric population, have increased the demand for virtual visits. The use of virtual visit platforms and services is very high among adults from high-income countries with good infrastructure, good internet access, and awareness. The pediatric group is expected to grow at a CAGR of 23.85% during the forecast period.

Segmentation by Component:
  • Service
  • Hardware
Segmentation by Application:
  • General Consultation
  • Behavioral Health
  • Chronic Care Management
  • Urgent Care
  • Others
Segmentation by Patient Group
  • Adults
  • Paediatric
GEOGRAPHICAL ANALYSIS

North America and Europe have the highest adoption rate of telehealth services due to high internet connectivity, increasing reimbursements, and full insurance coverage. In addition, North America dominates the critical vendor's presence. APAC, Latin America, and the Middle East & Africa region witnessed an increase in the adoption during a pandemic. However, limited reimbursement coverage, data security, privacy concern, lack of infrastructure, and a lack of consumer awareness of telehealth services are hindering the growth of the virtual visits market in these regions.

Segmentation by Geography
  • North America
  • US
  • Canada
  • Europe
  • UK
  • France
  • Germany
  • Italy
  • Spain
  • APAC
  • Japan
  • China
  • Australia
  • South Korea
  • India
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • The Middle East and Africa
  • Turkey
  • UAE
  • South Africa
KEY QUESTIONS ANSWERED

1. HOW BIG IS THE GLOBAL VIRTUAL VISITS MARKET?

2. WHAT IS THE GROWTH RATE OF THE GLOBAL VIRTUAL VISITS MARKET?

3. WHO ARE THE LEADING PLAYERS IN THE GLOBAL VIRTUAL VISITS MARKET?

4. WHICH REGION HAS THE HIGHEST NUMBER OF VIRTUAL VISITS SERVICE PROVIDERS?

5. WHAT IS THE GROWTH RATE OF THE HARDWARE AND SOFTWARE SEGMENT OF THE GLOBAL VIRTUAL VISITS MARKET?


1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY COMPONENT
4.3.2 MARKET SEGMENTATION BY APPLICATION
4.3.3 MARKET SEGMENTATION BY PATIENT GROUP
4.3.4 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 OVERVIEW
8 PREMIUM INSIGHTS
8.1 OVERVIEW
8.1.1 VENDOR ACTIVITIES IN THE MARKET
8.1.2 FACTORS CONTRIBUTING TO MARKET GROWTH
8.1.3 IMPACT OF COVID-19 PANDEMIC
8.1.4 MARKET ANALYSIS BY SEGMENTATION
9 MARKET OPPORTUNITIES & TRENDS
9.1 EMERGING SMART INTEGRATED DEVICES
9.2 INCREASING GROWTH OF VIRTUAL VISITS ACTIVITIES
9.3 INCREASING STRATEGIC PARTNERSHIPS & MERGERS/ACQUISITIONS
10 MARKET GROWTH ENABLERS
10.1 HIGHER REIMBURSEMENTS BY INSURERS AND GOVERNMENTS FOR VIRTUAL VISITS
10.2 LARGER TARGET POOL OF PATIENTS REQUIRING VIRTUAL VISITS
10.3 RISE OF VIRTUAL HOSPITALS
11 MARKET RESTRAINTS
11.1 LACK OF ACCESS TO FIXED INTERNET SERVICE
11.2 LEGAL BARRIERS & LACK OF STANDARD REGULATIONS FOR VIRTUAL VISITS
11.3 DATA SECURITY AND PRIVACY RISKS
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.2.1 COMPONENT
12.2.2 APPLICATION
12.2.3 PATIENT GROUP
12.2.4 GEOGRAPHY
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 COMPONENT
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 SERVICE
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 MARKET BY GEOGRAPHY
13.4 HARDWARE & SOFTWARE
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY
14 APPLICATION
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 GENERAL CONSULTATION
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.4 BEHAVIORAL HEALTH
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY
14.5 CHRONIC CARE MANAGEMENT
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 MARKET BY GEOGRAPHY
14.6 URGENT CARE
14.6.1 MARKET OVERVIEW
14.6.2 MARKET SIZE & FORECAST
14.6.3 MARKET BY GEOGRAPHY
14.7 OTHERS
14.7.1 MARKET OVERVIEW
14.7.2 MARKET SIZE & FORECAST
14.7.3 MARKET BY GEOGRAPHY
15 PATIENT GROUP
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 ADULTS
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 MARKET BY GEOGRAPHY
15.4 PEDIATRIC
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 MARKET BY GEOGRAPHY
16 GEOGRAPHY
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 GEOGRAPHIC OVERVIEW
17 NORTH AMERICA
17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.3 NORTH AMERICA: COMPONENT
17.4 NORTH AMERICA: APPLICATION
17.5 NORTH AMERICA: PATIENT GROUP
17.6 KEY COUNTRIES
17.6.1 US: MARKET SIZE & FORECAST
17.6.2 CANADA: MARKET SIZE & FORECAST
18 EUROPE
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 EUROPE: COMPONENT
18.4 EUROPE: APPLICATION
18.5 EUROPE: PATIENT GROUP
18.6 KEY COUNTRIES
18.6.1 UK: MARKET SIZE & FORECAST
18.6.2 FRANCE: MARKET SIZE & FORECAST
18.6.3 GERMANY: MARKET SIZE & FORECAST
18.6.4 ITALY: MARKET SIZE & FORECAST
18.6.5 SPAIN: MARKET SIZE & FORECAST
19 APAC
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 APAC: COMPONENT
19.4 APAC: APPLICATION
19.5 APAC: PATIENT GROUP
19.6 KEY COUNTRIES
19.6.1 JAPAN: MARKET SIZE & FORECAST
19.6.2 CHINA: MARKET SIZE & FORECAST
19.6.3 AUSTRALIA: MARKET SIZE & FORECAST
19.6.4 SOUTH KOREA: MARKET SIZE & FORECAST
19.6.5 INDIA: MARKET SIZE & FORECAST
20 LATIN AMERICA
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 LATIN AMERICA: COMPONENT
20.4 LATIN AMERICA: APPLICATION
20.5 LATIN AMERICA: PATIENT GROUP
20.6 KEY COUNTRIES
20.6.1 BRAZIL: MARKET SIZE & FORECAST
20.6.2 MEXICO: MARKET SIZE & FORECAST
20.6.3 ARGENTINA: MARKET SIZE & FORECAST
21 MIDDLE EAST & AFRICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.3 MIDDLE EAST & AFRICA: COMPONENT
21.4 MIDDLE EAST & AFRICA: APPLICATION
21.5 MIDDLE EAST & AFRICA: PATIENT GROUP
21.6 KEY COUNTRIES
21.6.1 TURKEY: MARKET SIZE & FORECAST
21.6.2 UAE: MARKET SIZE & FORECAST
21.6.3 SOUTH AFRICA: MARKET SIZE & FORECAST
22 COMPETITIVE LANDSCAPE
22.1 COMPETITION OVERVIEW
22.2 MARKET SHARE ANALYSIS
22.2.1 AMD GLOBAL TELEMEDICINE
22.2.2 AMERICAN WELL
22.2.3 KONINKLIJKE PHILIPS
22.2.4 TELADOC HEALTH
23 KEY COMPANY PROFILES
23.1 AMD GLOBAL TELEMEDICINE
23.1.1 BUSINESS OVERVIEW
23.1.1 PRODUCT OFFERINGS
23.1.2 KEY STRATEGIES
23.1.3 KEY STRENGTHS
23.1.4 KEY OPPORTUNITIES
23.2 AMERICAN WELL
23.2.1 BUSINESS OVERVIEW
23.2.2 PRODUCT OFFERINGS
23.2.3 KEY STRATEGIES
23.2.4 KEY STRENGTHS
23.2.5 KEY OPPORTUNITIES
23.3 KONINKLIJKE PHILIPS
23.3.1 BUSINESS OVERVIEW
23.3.2 PRODUCT OFFERINGS
23.3.3 KEY STRATEGIES
23.3.4 KEY STRENGTHS
23.3.5 KEY OPPORTUNITIES
23.4 TELADOC HEALTH
23.4.1 BUSINESS OVERVIEW
23.4.2 PRODUCT OFFERINGS
23.4.3 KEY STRATEGIES
23.4.4 KEY STRENGTHS
23.4.5 KEY OPPORTUNITIES
24 OTHER PROMINENT VENDORS
24.1 BANNER HEALTH
24.1.1 BUSINESS OVERVIEW
24.1.2 PRODUCT OFFERINGS
24.2 BEATO
24.2.1 BUSINESS OVERVIEW
24.2.2 PRODUCT OFFERINGS
24.3 BLUE SKY MD
24.3.1 BUSINESS OVERVIEW
24.3.2 PRODUCT OFFERINGS
24.4 CARECLIX
24.4.1 BUSINESS OVERVIEW
24.4.2 PRODUCT OFFERINGS
24.5 CERNER
24.5.1 BUSINESS OVERVIEW
24.5.2 SERVICE OFFERINGS
24.6 CHI HEALTH
24.6.1 BUSINESS OVERVIEW
24.6.2 PRODUCT OFFERINGS
24.7 CHIRON HEALTH
24.7.1 BUSINESS OVERVIEW
24.7.2 PRODUCT OFFERINGS
24.8 CVS HEALTH
24.8.1 BUSINESS OVERVIEW
24.8.2 PRODUCT OFFERINGS
24.9 DIALOGUE
24.9.1 BUSINESS OVERVIEW
24.9.2 PRODUCT OFFERINGS
24.10 DOCTOR ON DEMAND
24.10.1 BUSINESS OVERVIEW
24.10.2 PRODUCT OFFERINGS
24.11 DOXY.ME
24.11.1 BUSINESS OVERVIEW
24.11.2 PRODUCT OFFERINGS
24.12 EAGLE TELEMEDICINE
24.12.1 BUSINESS OVERVIEW
24.12.2 PRODUCT OFFERINGS
24.13 EDGEMED HEALTHCARE
24.13.1 BUSINESS OVERVIEW
24.13.2 PRODUCT OFFERINGS
24.14 EVISIT
24.14.1 BUSINESS OVERVIEW
24.14.2 PRODUCT OFFERINGS
24.15 HEALTHTAP
24.15.1 BUSINESS OVERVIEW
24.15.2 PRODUCT OFFERINGS
24.16 HEALTH AT HAND
24.16.1 BUSINESS OVERVIEW
24.16.2 PRODUCT OFFERINGS
24.17 HEALTHHERO
24.17.1 BUSINESS OVERVIEW
24.17.2 PRODUCT OFFERINGS
24.18 INSTAPRACT
24.18.1 BUSINESS OVERVIEW
24.18.2 PRODUCT OFFERINGS
24.19 MDLIVE
24.19.1 BUSINESS OVERVIEW
24.19.2 PRODUCT OFFERINGS
24.20 MEDIBUDDY
24.20.1 BUSINESS OVERVIEW
24.20.2 PRODUCT OFFERINGS
24.21 MFINE
24.21.1 BUSINESS OVERVIEW
24.21.2 PRODUCT OFFERINGS
24.22 NEUROSYNAPTIC COMMUNICATIONS
24.22.1 BUSINESS OVERVIEW
24.22.2 PRODUCT OFFERINGS
24.23 NEXTCARE
24.23.1 BUSINESS OVERVIEW
24.23.2 PRODUCT OFFERINGS
24.24 OPTUM
24.24.1 BUSINESS OVERVIEW
24.24.2 PRODUCT OFFERINGS
24.25 PLUSHCARE
24.25.1 BUSINESS OVERVIEW
24.25.2 PRODUCT OFFERINGS
24.26 PIEDMONT HEALTHCARE
24.26.1 BUSINESS OVERVIEW
24.26.2 PRODUCT OFFERINGS
24.27 PRACTO
24.27.1 BUSINESS OVERVIEW
24.27.2 PRODUCT OFFERINGS
24.28 RO
24.28.1 BUSINESS OVERVIEW
24.28.2 PRODUCT OFFERINGS
24.29 REECURO HEALTH
24.29.1 BUSINESS OVERVIEW
24.29.2 PRODUCT OFFERINGS
24.30 STEADYMD
24.30.1 BUSINESS OVERVIEW
24.30.2 PRODUCT OFFERINGS
24.31 SOC TELEMED
24.31.1 BUSINESS OVERVIEW
24.31.2 PRODUCT OFFERINGS
24.32 TRUDOC HEALTH CARE
24.32.1 BUSINESS OVERVIEW
24.32.2 PRODUCT OFFERINGS
24.33 VIDYO
24.33.1 BUSINESS OVERVIEW
24.33.2 PRODUCT OFFERINGS
24.34 VSEE
24.34.1 BUSINESS OVERVIEW
24.34.2 PRODUCT OFFERINGS
24.35 WALMART HEALTH VIRTUAL CARE
24.35.1 BUSINESS OVERVIEW
24.35.2 PRODUCT OFFERINGS
24.36 ZIPNOSIS
24.36.1 BUSINESS OVERVIEW
24.36.2 PRODUCT OFFERINGS
25 REPORT SUMMARY
25.1 KEY TAKEAWAYS
25.2 STRATEGIC RECOMMENDATIONS
26 QUANTITATIVE SUMMARY
26.1 MARKET BY GEOGRAPHY
26.2 MARKET BY COMPONENT
26.3 MARKET BY APPLICATION
26.4 MARKET BY PATIENT GROUP
26.5 NORTH AMERICA BY COMPONENT
26.6 NORTH AMERICA BY APPLICATION
26.7 NORTH AMERICA BY PATIENT GROUP
26.8 EUROPE BY COMPONENT
26.9 EUROPE BY APPLICATION
26.10 EUROPE BY PATIENT GROUP
26.11 APAC BY COMPONENT
26.12 APAC BY APPLICATION
26.13 APAC BY PATIENT GROUP
26.14 LATIN AMERICA BY COMPONENT
26.15 LATIN AMERICA BY APPLICATION
26.16 LATIN AMERICA BY PATIENT GROUP
26.17 MIDDLE EAST & AFRICA BY COMPONENT
26.18 MIDDLE EAST & AFRICA BY APPLICATION
26.19 MIDDLE EAST & AFRICA BY PATIENT GROUP
27 APPENDIX
27.1 ABBREVIATIONS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings